| pubmed-article:19424036 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C0805586 | lld:lifeskim |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C0678756 | lld:lifeskim |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19424036 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:19424036 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19424036 | pubmed:dateCreated | 2009-5-8 | lld:pubmed |
| pubmed-article:19424036 | pubmed:abstractText | The Symphony study compared four immunosuppressant regimens, defined by protocol-specified target drug concentrations. This subanalysis examines actual drug levels and the implications on the interpretation of results. | lld:pubmed |
| pubmed-article:19424036 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19424036 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19424036 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19424036 | pubmed:month | May | lld:pubmed |
| pubmed-article:19424036 | pubmed:issn | 1534-6080 | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:PearsonThomas... | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:EkbergHenrikH | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:VincentiFlavi... | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:DalozePierreP | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:MamelokRichar... | lld:pubmed |
| pubmed-article:19424036 | pubmed:author | pubmed-author:Tedesco-Silva... | lld:pubmed |
| pubmed-article:19424036 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19424036 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19424036 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:19424036 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19424036 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19424036 | pubmed:pagination | 1360-6 | lld:pubmed |
| pubmed-article:19424036 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:meshHeading | pubmed-meshheading:19424036... | lld:pubmed |
| pubmed-article:19424036 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19424036 | pubmed:articleTitle | The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. | lld:pubmed |
| pubmed-article:19424036 | pubmed:affiliation | Department of Nephrology and Transplantation, University Hospital, Lund University, Malmö, Sweden. henrik.ekberg@med.lu.se | lld:pubmed |
| pubmed-article:19424036 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19424036 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
